Table 1.

Viability of normal rat kidney (NRK) cells treated with resveratrol, lovastatin, RAD-001, insulin and combinations with insulin.

	Treatment	Viability (%)
Group I	Control	95.33 ± 0.58
	Resveratrol	96.12 ± 1.53
	10 nM Insulin	97.00 ± 1.00
	100 nM Insulin	95.83 ± 1.15
	Resveratrol + 10 nM Insulin	97.12 ± 1.53
	Resveratrol + 100 nM Insulin	97.67 ± 1.15
Group II	Control	95.17 ± 1.53
	Lovastatin	95.17 ± 0.58
	10 nM Insulin	97.38 ± 1.15
	100 nM Insulin	96.34 ± 1.53
	Lovastatin + 10 nM Insulin	97.12 ± 1.15
	Lovastatin + 100 nM Insulin	95.67 ± 1.53
Group III	Control	98.00 ± 1.00
	RAD-001	97.67 ± 0.83
	10 nM Insulin	98.17 ± 1.53
	RAD-001 + 10 nM Insulin	95.67 ± 1.53